健康元: 健康元药业集团股份有限公司关于荷兰子公司获得生产许可证的公告

Group 1 - The core announcement is that JOINCARE PHARMA NETHERLANDS B.V., a wholly-owned subsidiary of the company, has received a production license from the Dutch Ministry of Health, Welfare and Sport [1] - The license allows for the import of pharmaceuticals and is effective from June 1, 2025 [1] - This development is expected to facilitate the company's entry into the EU market, enhancing its brand influence and competitiveness in the international pharmaceutical market [1] Group 2 - The company plans to accelerate the application for marketing authorization of related products in EU member states, aiming to promote international sales [1]